New long-term results show that zoledronic acid can prevent bone loss in breast cancer patients receiving estrogen-reducing adjuvant therapies. Medscape Medical News
The use of intensive insulin therapy placed patients critically ill with sepsis at increased risk for serious adverse events related to hypoglycemia, and pentastarch was also harmful. Medscape Medical News